American Journal of Obstetrics & Gynecology
Volume 201, Issue 3 , Pages 263.e1-263.e9 , September 2009

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors

Presented as a poster at the 55th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, San Diego, CA, May 5-9, 2007.

  • Jürgen C. Dinger, MD, PhD

      Affiliations

    • ZEG–Center for Epidemiology and Health Research, Berlin, Germany
    • Corresponding Author InformationReprints: Jürgen C. Dinger, MD, PhD, ZEG–Centre for Epidemiology and Health Research, Invalidenstrasse 115, 10115 Berlin, Germany
    • ,
  • Maureen Cronin, MD, PhD

      Affiliations

    • Bayer Schering Pharma AG, Berlin, Germany
    • ,
  • Sabine Möhner, PhD

      Affiliations

    • ZEG–Center for Epidemiology and Health Research, Berlin, Germany
    • ,
  • Ilka Schellschmidt, MD

      Affiliations

    • Bayer Schering Pharma AG, Berlin, Germany
    • ,
  • Thai Do Minh, PhD

      Affiliations

    • ZEG–Center for Epidemiology and Health Research, Berlin, Germany
    • ,
  • Carolyn Westhoff, MD, MSc

      Affiliations

    • Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY

Received 20 October 2008 ,Revised 26 January 2009 ,Accepted 6 March 2009.

References 

  1. Trussell J. Contraceptive efficacy. In:  Hatcher RA,  Trussell J,  Nelson AL,  Cates W,  Stewart FH,  Kowal D editor. Contraceptive technology. 18th ed.. New York: Ardent Media; 2007;p. 792
  2. Food and Drug Administration. Transcript: Advisory Committee for Reproductive Health Drugs, January 24, 2007. http://www.fda.gov/OHRMS/DOCKETS/AC/07/transcripts/2007-4274t2-part2.pdfAccessed Jan. 7, 2009
  3. Brunner Huber LR, Hogue CJ. The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception. Matern Child Health J. 2005;9:413–420
  4. Holt VL, Cushing-Haugen KL, Daling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol. 2002;99:820–827
  5. Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105:46–52
  6. Brunner Huber LR, Hogue CJ, Stein AD, Drews C, Zieman M. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann Epidemiol. 2006;16:637–643
  7. Brunner Huber LR, Toth JL. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol. 2007;166:1306–1311
  8. Brunner LR, Hogue CJ. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth. Ann Epidemiol. 2005;15:492–499
  9. Vessey M. Oral contraceptive failures and body weight: findings in a large cohort study. J Fam Plann Reprod Health Care. 2001;27:90–91
  10. Dinger JC, Heinemann LAJ, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception. 2007;75:344–354
  11. European Medicines Agency Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women, July 27, 2005. http://www.emea.europa.eu/pdfs/human/ewp/051998en.pdfAccessed Jan. 6, 2009
  12. Gerlinger C, Endrikat J, van der Meulen EA, Dieben TO, Dusterberg B. Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care. 2003;8:87–92
  13. Gallegos AJ, Gonzáles-Diddi M, Merino G, Martínez-Manautou J. Tissue localization of radioactive chlormadinone acetate and progesterone in the human. Contraception. 1970;1:151–161
  14. Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep. 2003;51:1–94
  15. Larsen U, Yan S. The age pattern of fecundability: an analysis of French Canadian and Hutterite birth histories. Soc Biol. 2000;47:34–50
  16. Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol. 1989;11:61–109
  17. Cronin M, Möhner S, Minh Thai D, Westhoff C. Past oral contraception use does not negatively affect time to conception. Obstet Gynecol. 2007;109:3S
  18. Trussell J. Methodological pitfalls in the analysis of contraceptive failure. Stat Med. 1991;10:201–220
  19. Howe G, Westhoff C, Vessey M, Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J (Clin Res Ed). 1985;290:1697–1700
  20. Cronin M, Möhner S, Dinger J, Schellschmidt I. Return to fertility after use of oral contraceptives: results from the EURAS study. In: Proceedings of the 9th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI). Barcelona, Spain, March 22-25, 2007. 2007;A-68
  21. Nyholm M, Gullberg B, Merlo J, Lundqvist-Persson C, Rastam L, Lindblad U. The validity of obesity based on self-reported weight and height: Implications for population studies. Obesity (Silver Spring). 2007;15:197–208
  22. Visscher TL, Viet AL, Kroesbergen IH, Seidell JC. Underreporting of BMI in adults and its effect on obesity prevalence estimations in the period 1998 to 2001. Obesity (Silver Spring). 2006;14:2054–2063
  23. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77:10–21
  24. Darney P. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. Contraception. 1993;48:323–337
  25. Ferguson H, Vree ML, Wilpshaar J, Eskes TK. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. Eur J Contracept Reprod Health Care. 2000;5:35–45
  26. Grubb GS, Archer DF, Constantine GD. Differences between the United States and Europe in clinical trials of hormonal contraceptive efficacy. Obstet Gynecol. 2008;111:63S
  27. Salas M, Kiefe CI, Schreiner PJ, et al. Obesity modifies the association of race/ethnicity with medication adherence in the CARDIA study. The Patient. 2008;1:41–54

 Cite this article as: Dinger JC, Cronin M, Möhner S, et al. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol 2009;201:263.e1-9.

 Financial support was provided by Bayer Schering Pharma AG, Berlin, Germany.

PII: S0002-9378(09)00272-5

doi: 10.1016/j.ajog.2009.03.017

American Journal of Obstetrics & Gynecology
Volume 201, Issue 3 , Pages 263.e1-263.e9 , September 2009

Article Tools

* Image Usage & Resolution